Ignacio Quevedo-Romero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ignacio Quevedo-Romero has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Gila-Navarro
Genética Molecular, Instituto de Biotecnología Vegetal, Edificio I+D+I, Plaza del Hospital s/n, Universidad Politécnica de Cartagena, 30202 Cartagena, Spain
2 shared publications - Alise Jany Ponsero
Faculty of Medicine, University of Helsinki, Helsinki, Finland
2 shared publications - Andrea Telatin
Quadram Institute Bioscience, Norwich Research Park, Norwich, UK
2 shared publications Caridad Soto
2 shared publicationsCovadonga Valle Alcaraz
2 shared publications- Enriqueta Garcia-Gutierrez
Quadram Institute Bioscience
2 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Elsevier in SSRN Electronic Journal
Lactiplantibacillus plantarum IBB082 inoculation shapes microbial succession, metabolite profile and immunomodulatory potential in traditional short-term Romanian cucumber fermentations
Romanian fermented cucumbers are traditionally produced by spontaneous lactic acid fermentation at household level and may represent valuable sources of beneficial lactic acid bacteria (LAB) and bioactive metabolites. However, their microbial composition, functional properties, and safety under in-house conditions remain poorly characterised. In this study, Romanian-style fermented cucumbers were produced over the lowest range of typical household fermentation, a two-week period, using either spontaneous fermentation or inoculation with Lactiplantibacillus plantarum IBB082. Microbial community dynamics were characterised by 16S rRNA gene amplicon sequencing, while fermentation-derived metabolites were identified by untargeted analytical assays. Total phenolic compounds and antioxidant capacity were also evaluated. Spontaneous fermentations showed greater microbial variability, whereas Lactiplantibacillus-inoculated fermentations exhibited faster LAB dominance and more consistent acidification. Moreover, fermentation in the presence of L. plantarum IBB082 was associated with distinct metabolite profiles and enhanced antioxidant capacity. Additionally, both fermentation strategies activated NF-κB in IL-1β-stimulated intestinal epithelial cells, suggesting a potential immunomodulatory response. These results were then compared with those of a commercial product. To our knowledge, this is the first study integrating metataxonomic, metabolomic, immunoregulatory and molecular safety profiling in short-term household-style Romanian cucumber fermentations, providing a comprehensive framework for the characterisation and quality control of traditional artisanal fermented foods.
- 12 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLactiplantibacillus plantarum IBB082 inoculation shapes microbial succession, metabolite profile and immunomodulatory potential in traditional short-term Romanian cucumber fermentations
Romanian fermented cucumbers are traditionally produced by spontaneous lactic acid fermentation at household level and may represent valuable sources of beneficial lactic acid bacteria (LAB) and bioactive metabolites. However, their microbial composition, functional properties, and safety under in-house conditions remain poorly characterised. In this study, Romanian-style fermented cucumbers were produced over the lowest range of typical household fermentation, a two-week period, using either spontaneous fermentation or inoculation with Lactiplantibacillus plantarum IBB082. Microbial community dynamics were characterised by 16S rRNA gene amplicon sequencing, while fermentation-derived metabolites were identified by untargeted analytical assays. Total phenolic compounds and antioxidant capacity were also evaluated. Spontaneous fermentations showed greater microbial variability, whereas Lactiplantibacillus-inoculated fermentations exhibited faster LAB dominance and more consistent acidification. Moreover, fermentation in the presence of L. plantarum IBB082 was associated with distinct metabolite profiles and enhanced antioxidant capacity. Additionally, both fermentation strategies activated NF-κB in IL-1β-stimulated intestinal epithelial cells, suggesting a potential immunomodulatory response. These results were then compared with those of a commercial product. To our knowledge, this is the first study integrating metataxonomic, metabolomic, immunoregulatory and molecular safety profiling in short-term household-style Romanian cucumber fermentations, providing a comprehensive framework for the characterisation and quality control of traditional artisanal fermented foods.
- Open Access
- 25 December 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
MSC administration resolves experimental acute gout increasing specialized pro-resolving mediators synthesis through a super-induction of prostaglandin E2
The resolution of inflammation is an active process triggered in the acute phase of inflammation and mainly directed by specialized pro-resolving mediators
- 25 December 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
Open AccessMSC administration resolves experimental acute gout increasing specialized pro-resolving mediators synthesis through a super-induction of prostaglandin E2
The resolution of inflammation is an active process triggered in the acute phase of inflammation and mainly directed by specialized pro-resolving mediators
- Open Access
ND-13, a DJ-1 derived peptide, as a novel pharmacological approach in the prevention of NLRP3 inflammasome activity in Diabetic Nephropathy
Diabetic nephropathy is the most important cause of renal failure worldwide and is characterized by sustained inflammation regulated in part by NLRP3 Inflammasome. Attenuation of inflammation is a major priority to prevent renal damage. Our previous publications show that DJ-1 has antioxidant and anti-inflammatory properties in the kidney. ND-13 is a short peptide consisting of 13 amino acids of the DJ-1-protein, which could increase DJ-1 pathway activation. The aim of these studies was to determine the role of NLRP3 in the pathogenesis of diabetic nephropathy and to study the possible renal protective effects of the DJ-1 pathway in diabetic mice and on inflammasome regulation. Bone marrow derived macrophages were treated with ND-13 and cultivated in high and low glucose. Diabetes was induced in C57Bl/6 mice via injection of streptozotocin and treated with ND-13 and MCC950, an inhibitor of the NLRP3 inflammasome. Peripheral mononuclear cells were isolated from human with diabetes, diabetic nephropathy and healthy donors and were plated, pretreated with ND-13 and stimulated with LPS+ATP. IL-1β concentration in the medium of bone marrow derived macrophages increased by NLRP3 inflammasome stimulation by LPS+ATP, and decreased in macrophages pre-treated with ND-13, however, in the presence of LPS+Nigericin no effect was found. Peritoneal macrophages from diabetic mice were obtained and plated. Streptozotocin-induced diabetic C57BL/6 mice have increased the peritoneal cells IL-1β production compared with control mice, suggesting that inflammasome may be activated in macrophages during diabetes and that ND-13 treatment normalized its activity. ND-13 and MCC950 decreased histologic evidence of tubular injury in STZ-induced diabetes in mice, additionally, significantly increased the mRNA expression of Col-I, Col-II, Tgf-β, Il-6, Tnf-α and P2x7 in the renal cortex, which was partially prevented by ND-13 and MCC950 pre-treatment. P2x7 mRNA expression was also increased in peritoneal macrophages obtained from diabetic mice, and its expression was attenuated by ND-13 pre-treatment. Peripheral mononuclear cells isolated from patient’s blood were plated and stimulated with LPS+ATP. Patients with diabetic nephropathy presented a significant increase of IL-1β release compared to diabetic individuals and ND-13 could has a role in the prevention of inflammasome activation in healthy patients. Our results demonstrate that activation of the DJ-1 pathway is a promising approach to prevent renal inflammation and fibrosis during diabetes, by ameliorating inflammasome activation in peripheral immune cells. Thus, ND-13 could be a promising new therapeutic approach to attenuating inflammation and renal damage in diabetic nephropathy.
Open AccessND-13, a DJ-1 derived peptide, as a novel pharmacological approach in the prevention of NLRP3 inflammasome activity in Diabetic Nephropathy
Diabetic nephropathy is the most important cause of renal failure worldwide and is characterized by sustained inflammation regulated in part by NLRP3 Inflammasome. Attenuation of inflammation is a major priority to prevent renal damage. Our previous publications show that DJ-1 has antioxidant and anti-inflammatory properties in the kidney. ND-13 is a short peptide consisting of 13 amino acids of the DJ-1-protein, which could increase DJ-1 pathway activation. The aim of these studies was to determine the role of NLRP3 in the pathogenesis of diabetic nephropathy and to study the possible renal protective effects of the DJ-1 pathway in diabetic mice and on inflammasome regulation. Bone marrow derived macrophages were treated with ND-13 and cultivated in high and low glucose. Diabetes was induced in C57Bl/6 mice via injection of streptozotocin and treated with ND-13 and MCC950, an inhibitor of the NLRP3 inflammasome. Peripheral mononuclear cells were isolated from human with diabetes, diabetic nephropathy and healthy donors and were plated, pretreated with ND-13 and stimulated with LPS+ATP. IL-1β concentration in the medium of bone marrow derived macrophages increased by NLRP3 inflammasome stimulation by LPS+ATP, and decreased in macrophages pre-treated with ND-13, however, in the presence of LPS+Nigericin no effect was found. Peritoneal macrophages from diabetic mice were obtained and plated. Streptozotocin-induced diabetic C57BL/6 mice have increased the peritoneal cells IL-1β production compared with control mice, suggesting that inflammasome may be activated in macrophages during diabetes and that ND-13 treatment normalized its activity. ND-13 and MCC950 decreased histologic evidence of tubular injury in STZ-induced diabetes in mice, additionally, significantly increased the mRNA expression of Col-I, Col-II, Tgf-β, Il-6, Tnf-α and P2x7 in the renal cortex, which was partially prevented by ND-13 and MCC950 pre-treatment. P2x7 mRNA expression was also increased in peritoneal macrophages obtained from diabetic mice, and its expression was attenuated by ND-13 pre-treatment. Peripheral mononuclear cells isolated from patient’s blood were plated and stimulated with LPS+ATP. Patients with diabetic nephropathy presented a significant increase of IL-1β release compared to diabetic individuals and ND-13 could has a role in the prevention of inflammasome activation in healthy patients. Our results demonstrate that activation of the DJ-1 pathway is a promising approach to prevent renal inflammation and fibrosis during diabetes, by ameliorating inflammasome activation in peripheral immune cells. Thus, ND-13 could be a promising new therapeutic approach to attenuating inflammation and renal damage in diabetic nephropathy.